BlackRock, Inc. 13D and 13G filings for Meridian Bioscience, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-26 08:52 am Unchanged |
2022-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
BLACKROCK INC BLK |
7,557,772 17.200% |
0 (Unchanged) |
Filing |
| 2023-01-20 5:17 pm Purchase |
2022-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
BLACKROCK INC BLK |
7,557,772 17.200% |
151,847 (+2.05%) |
Filing |
| 2022-01-27 11:00 am Unchanged |
2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
BLACKROCK INC BLK |
7,405,925 17.000% |
0 (Unchanged) |
Filing |
| 2022-01-25 3:03 pm Purchase |
2021-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
BLACKROCK INC BLK |
7,405,925 17.000% |
558,178 (+8.15%) |
Filing |
| 2021-01-25 4:50 pm Sale |
2020-12-31 | 13G | Meridian Bioscience, Inc. VIVO |
BLACKROCK INC BLK |
6,847,747 15.900% |
-58,462 (-0.85%) |
Filing |